On April 6, 2022 SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, reported that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the 21st Annual Needham Virtual Healthcare Conference on April 13, and Chardan’s 6th Annual Genetic Medicines & Cell Therapy Manufacturing Summit on April 26 (Press release, SQZ Biotech, APR 6, 2022, View Source [SID1234611533]). Presentation times and webcast information are available below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

PRESENTATION DETAILS

Wednesday, April 13
21st Annual Needham Virtual Healthcare Conference
9:30-10:10 am ET
Webcast

Tuesday, April 26
Chardan’s 6th Annual Genetic Medicines & Cell Therapy Manufacturing Summit
10:00-10:25 am ET
Webcast

Conference webcast details and the company’s most recent corporate overview presentation will be available on the Investors section of the SQZ website.